Saturday, 30 March 2019

Activist Starboard drops out of Celgene fight as proxy firms back Bristol-Myers bid

Activist investor Starboard Value has ended its fight against Bristol-Myers Squibb's buyout of biotechnology company Celgene.

from Health and Science https://ift.tt/2TI6JhN
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)